+$703.6M
Net Activity
Institutions Holding
217
Popularity Rank
#2692
Avg Weight
0.42%
Total Value
$3.7B
217 institutions currently hold EWTX, with 103 net buyers and 92 net sellers this quarter.
Institutional Moves (Q1 2026)
Neutral
Based on recent trading activity
Net Selling Institutions
92
Net Buying Institutions
103
Top 5 by Value
+$1.1B
Total Buy Value
$1.2B
Total Sell Value
103
Net Buyers
92
Net Sellers
1
Filings (90d)
$8.13M
Total Est. Value
200K shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| ALAN J RUSSELL | 2026-07-01 | $8.13M |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
No Schedule 13D/13G filings for this ticker
2
Filings (14d)
Edgewise Therapeutics filed a Form 8-K with the SEC on July 10, 2026, to provide unaudited pro forma condensed financial information as Exhibit 99.1. The filing covers only Item 9.01, which pertains to financial statements and exhibits. No other events, changes in management, or material transactions were announced in this filing.
View Full Filing (SEC EDGAR)Edgewise Therapeutics has completed the sale of its muscular dystrophy program, including the sevasemten compound, to Servier Pharmaceuticals LLC and Les Laboratoires Servier. The deal closed on July 10, 2026, with $1.55 billion in upfront cash and up to $1.1 billion in additional milestone payments, for a total potential consideration of $2.65 billion. This transaction was previously announced in June 2026.
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter